nifedipine has been researched along with pentoxifylline in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.41) | 18.7374 |
| 1990's | 6 (22.22) | 18.2507 |
| 2000's | 12 (44.44) | 29.6817 |
| 2010's | 6 (22.22) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Haustein, UF | 1 |
| Demusz, CD; Weselcouch, EO | 1 |
| Friederichs, E; Rädisch, T; Winkler, H | 1 |
| Beykirch, H; Herrmann, W; Reuter, W; Voigt, H | 1 |
| Calleja, F; Casares, J; Chacón-Quevedo, A; Concha, M; Eguaras, MG; Garcia, MA; Muñoz, I; Roman, M | 1 |
| Evans, WK; Logan, D; Stewart, DJ | 1 |
| Akopov, SE; Gabrielian, ES | 1 |
| Oonishi, T; Sakashita, K; Uyesaka, N | 1 |
| Bulaeva, SV; Chuchkanov, FA; Maimistova, AA; Muravyov, AV; Yakusevich, VV; Zaitsev, LG | 1 |
| Buell, C; Lamp, K; Tobinick, E | 1 |
| Ertem, K | 1 |
| Horvath, B; Kesmarky, G; Toth, K; Vekasi, J | 1 |
| Araújo, AC; Jorge, VC; Noronha, C; Panarra, A; Riso, N; Vaz Riscado, M | 1 |
| Acar, M; Dogan, B; Senel, S; Zorlu, P | 1 |
| Kirchhof, MG; Mahmood, F; Pratt, M | 1 |
3 review(s) available for nifedipine and pentoxifylline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Current status and trends in treatment of scleroderma].
Topics: Captopril; Combined Modality Therapy; Dextrans; Epoprostenol; Humans; Immunosuppressive Agents; Nifedipine; Pentoxifylline; Scleroderma, Systemic | 1992 |
Pharmacologic Treatment of Idiopathic Chilblains (Pernio): A Systematic Review.
Topics: Chilblains; Humans; Nifedipine; Pentoxifylline; Vasodilator Agents | 2021 |
2 trial(s) available for nifedipine and pentoxifylline
| Article | Year |
|---|---|
Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs.
Topics: Adult; Aged; Blood Pressure; Double-Blind Method; Exercise Test; Humans; Intermittent Claudication; Male; Middle Aged; Nifedipine; Pentoxifylline; Prospective Studies; Pyrrolidines; Vasodilator Agents; Walking | 1994 |
The relationship between the degradation of prostacyclin in blood and antiplatelet drug effects in patients with atherosclerosis.
Topics: Arteriosclerosis; Dipyridamole; Double-Blind Method; Epoprostenol; Humans; Kinetics; Middle Aged; Nifedipine; Pentoxifylline; Platelet Aggregation; Platelet Aggregation Inhibitors | 1993 |
22 other study(ies) available for nifedipine and pentoxifylline
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Drug effects on function in the ferret ischemic hindlimb.
Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Electric Stimulation; Ferrets; Hindlimb; Ischemia; Isometric Contraction; Male; Muscle Contraction; Nifedipine; Pentoxifylline; Regional Blood Flow | 1990 |
Calcium content of the erythrocytes: a sensitive and easy handling method for measuring free calcium ions, and modulation of the Ca2+ ion concentration by the calcium antagonists nifedipine and pentoxifylline.
Topics: Adenosine Triphosphate; Calcimycin; Calcium; Erythrocytes; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Ionophores; Nifedipine; Pentoxifylline; Temperature; Theobromine | 1989 |
[Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline].
Topics: Arteriosclerosis Obliterans; Hemodynamics; Humans; Ischemia; Leg; Lipids; Male; Middle Aged; Nifedipine; Pentoxifylline; Theobromine | 1989 |
Addition of pentoxifylline plus nifedipine to chemotherapy in patients with cisplatin-resistant cancers of the lung and other sites.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Evaluation; Drug Resistance; Female; Humans; Hypotension; Lung Neoplasms; Male; Neutropenia; Nifedipine; Ovarian Neoplasms; Pentoxifylline | 1994 |
Regulation of red blood cell filterability by Ca2+ influx and cAMP-mediated signaling pathways.
Topics: Adult; Alprostadil; Calcium; Calcium Channel Blockers; Cyclic AMP; Dinoprostone; Epinephrine; Erythrocyte Deformability; Erythrocytes; Felodipine; Filtration; Humans; In Vitro Techniques; Kinetics; Male; Nifedipine; Pentoxifylline; Signal Transduction; Stress, Mechanical | 1997 |
Hemorheological efficiency of drugs, targeting on intracellular phosphodiesterase activity: in vitro study.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Blood Viscosity; Caffeine; Calcimycin; Calcium; Egtazic Acid; Erythrocyte Aggregation; Hemorheology; Humans; Male; Nifedipine; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Verapamil; Vinca Alkaloids | 2007 |
Resolution of chronic pain and fingertip ulceration due to hand-arm vibration syndrome following combination pharmacotherapy.
Topics: Chronic Disease; Drug Therapy, Combination; Hand-Arm Vibration Syndrome; Humans; Male; Middle Aged; Nifedipine; Pain; Pentoxifylline; Raynaud Disease; Skin Ulcer; Vasodilator Agents | 2007 |
Prolonged transient hand ischaemia secondary to a penicillin skin test.
Topics: Aspirin; Calcium Channel Blockers; Cyanosis; Drug Hypersensitivity; Drug Therapy, Combination; Fibrinolytic Agents; Fingers; Follow-Up Studies; Hand; Humans; Intradermal Tests; Ischemia; Male; Middle Aged; Nadroparin; Nifedipine; Penicillins; Pentoxifylline; Vasodilator Agents | 2007 |
In vitro antioxidant properties of pentoxifylline and vinpocetine in a rheological model.
Topics: Adult; Blood Viscosity; Caffeine; Calcimycin; Calcium; Egtazic Acid; Erythrocyte Aggregation; Free Radical Scavengers; Hemorheology; Humans; Male; Nifedipine; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Verapamil; Vinca Alkaloids | 2008 |
Buerger's disease (Thromboangiitis obliterans): a diagnostic challenge.
Topics: Adult; Angiography; Aspirin; Atorvastatin; Calcium Channel Blockers; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iloprost; Male; Nifedipine; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrroles; Smoking Cessation; Thromboangiitis Obliterans | 2011 |
Successfully treated fingertip necrosis in an infant with primary Raynaud phenomenon.
Topics: Anticoagulants; Drug Therapy, Combination; Enoxaparin; Fingers; Humans; Infant; Male; Necrosis; Nifedipine; Pentoxifylline; Raynaud Disease; Vasodilator Agents | 2014 |